Blue Fin Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.58M | Sell |
7,338
-106
| -1% | -$37.8K | 0.42% | 48 |
|
|
2025
Q4 | $2.44M | Buy |
7,444
+1,477
| +25% | +$469K | 0.38% | 49 |
|
|
2025
Q3 | $1.68M | Sell |
5,967
-44
| -0.7% | -$12.8K | 0.26% | 55 |
|
|
2025
Q2 | $1.68M | Sell |
6,011
-48
| -0.8% | -$13.6K | 0.29% | 57 |
|
|
2025
Q1 | $1.89M | Sell |
6,059
-83
| -1% | -$24.5K | 0.37% | 53 |
|
|
2024
Q4 | $1.6M | Buy |
6,142
+1,431
| +30% | +$425K | 0.3% | 57 |
|
|
2024
Q3 | $1.52M | Sell |
4,711
-113
| -2% | -$37K | 0.29% | 60 |
|
|
2024
Q2 | $1.51M | Buy |
4,824
+56
| +1% | +$16.5K | 0.3% | 59 |
|
|
2024
Q1 | $1.36M | Sell |
4,768
-177
| -4% | -$51.8K | 0.3% | 59 |
|
|
2023
Q4 | $1.42M | Sell |
4,945
-105
| -2% | -$28.6K | 0.37% | 55 |
|
|
2023
Q3 | $1.36M | Sell |
5,050
-126
| -2% | -$31.4K | 0.4% | 58 |
|
|
2023
Q2 | $1.15M | Sell |
5,176
-78
| -1% | -$18.1K | 0.33% | 64 |
|
|
2023
Q1 | $1.22M | Sell |
5,254
-343
| -6% | -$84.2K | 0.39% | 58 |
|
|
2022
Q4 | $1.47M | Sell |
5,597
-314
| -5% | -$84.2K | 0.54% | 49 |
|
|
2022
Q3 | $1.33M | Buy |
5,911
+428
| +8% | +$104K | 0.5% | 54 |
|
|
2022
Q2 | $1.33M | Sell |
5,483
-60
| -1% | -$14.7K | 0.47% | 55 |
|
|
2022
Q1 | $1.34M | Buy |
5,543
+36
| +0.7% | +$8.27K | 0.39% | 58 |
|
|
2021
Q4 | $1.24M | Buy |
5,507
+29
| +0.5% | +$6.12K | 0.34% | 61 |
|
|
2021
Q3 | $1.16M | Sell |
5,478
-86
| -2% | -$19.8K | 0.36% | 61 |
|
|
2021
Q2 | $1.36M | Sell |
5,564
-220
| -4% | -$54.1K | 0.42% | 59 |
|
|
2021
Q1 | $1.44M | Sell |
5,784
-374
| -6% | -$89.2K | 0.49% | 57 |
|
|
2020
Q4 | $1.42M | Sell |
6,158
-38
| -0.6% | -$8.76K | 0.51% | 53 |
|
|
2020
Q3 | $1.57M | Buy |
6,196
+67
| +1% | +$16.6K | 0.64% | 41 |
|
|
2020
Q2 | $1.45M | Sell |
6,129
-543
| -8% | -$124K | 0.64% | 41 |
|
|
2020
Q1 | $1.35M | Sell |
6,672
-255
| -4% | -$55.7K | 0.75% | 42 |
|
|
2019
Q4 | $1.67M | Sell |
6,927
-126
| -2% | -$27.8K | 0.79% | 36 |
|
|
2019
Q3 | $1.36M | Sell |
7,053
-559
| -7% | -$107K | 0.71% | 43 |
|
|
2019
Q2 | $1.4M | Buy |
7,612
+36
| +0.5% | +$6.45K | 0.72% | 42 |
|
|
2019
Q1 | $1.44M | Buy |
7,576
+46
| +0.6% | +$8.79K | 0.76% | 39 |
|
|
2018
Q4 | $1.47M | Buy |
7,530
+81
| +1% | +$15.8K | 0.87% | 30 |
|
|
2018
Q3 | $1.54M | Buy |
7,449
+677
| +10% | +$133K | 0.76% | 35 |
|
|
2018
Q2 | $1.25M | Buy |
6,772
+96
| +1% | +$17K | 0.67% | 42 |
|
|
2018
Q1 | $1.14M | Hold |
6,676
| – | – | 0.64% | 43 |
|
|
2017
Q4 | $1.16M | Buy |
6,676
+370
| +6% | +$65.5K | 0.68% | 44 |
|
|
2017
Q3 | $1.18M | Hold |
6,306
| – | – | 0.72% | 41 |
|
|
2017
Q2 | $1.09M | Buy |
6,306
+65
| +1% | +$10.6K | 0.7% | 44 |
|
|
2017
Q1 | $1.02M | Buy |
6,241
+370
| +6% | +$61.5K | 0.63% | 50 |
|
|
2016
Q4 | $859K | Buy |
5,871
+1,278
| +28% | +$192K | 0.57% | 56 |
|
|
2016
Q3 | $766K | Sell |
4,593
-100
| -2% | -$16.9K | 0.62% | 51 |
|
|
2016
Q2 | $714K | Sell |
4,693
-5
| -0.1% | -$777 | 0.59% | 57 |
|
|
2016
Q1 | $704K | Sell |
4,698
-1,114
| -19% | -$166K | 0.6% | 55 |
|
|
2015
Q4 | $943K | Sell |
5,812
-133
| -2% | -$20.9K | 0.73% | 48 |
|
|
2015
Q3 | $822K | Sell |
5,945
-50
| -0.8% | -$7.88K | 0.64% | 51 |
|
|
2015
Q2 | $920K | Buy |
5,995
+145
| +2% | +$23.2K | 0.66% | 49 |
|
|
2015
Q1 | $935K | Buy |
5,850
+305
| +6% | +$48K | 0.68% | 51 |
|
|
2014
Q4 | $883K | Buy |
5,545
+25
| +0.5% | +$3.9K | 0.67% | 52 |
|
|
2014
Q3 | $775K | Sell |
5,520
-105
| -2% | -$13.7K | 0.61% | 55 |
|
|
2014
Q2 | $666K | Buy |
5,625
+375
| +7% | +$43.4K | 0.53% | 60 |
|
|
2014
Q1 | $648K | Sell |
5,250
-805
| -13% | -$97.6K | 0.57% | 60 |
|
|
2013
Q4 | $691K | Buy |
+6,055
| New | +$689K | 0.62% | 59 |
|
Other funds holding AMGN
VCM
VPM
Blue Fin Capital's AMGN Position: Q1 2026 in Review
Blue Fin Capital reduced its Amgen (AMGN) stake by 1.4% in Q1 2026, selling an estimated $37.8K and leaving 7,338 shares worth $2.58M. The position accounts for 0.42% of the portfolio, ranked #48.
Blue Fin Capital first reported a position in AMGN in Q4 2013 and has held it in 50 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Blue Fin Capital held 7,338 shares of Amgen worth $2.58M as of Q1 2026.
- Blue Fin Capital sold 106 Amgen shares in Q1 2026, an estimated $37.8K.
- Amgen made up 0.42% of Blue Fin Capital's portfolio in Q1 2026, its #48 holding.
- Blue Fin Capital first reported a position in Amgen in Q4 2013 and has held it in 50 quarters since.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Blue Fin Capital's 13F filing for Q1 2026, filed 28 May 2026.